NYSE$UNH
UnitedHealth · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
UnitedHealth Group's Q1 2024 results reflected growth in Optum and UnitedHealthcare, with medical care activity as expected, but were impacted by the Change Healthcare cyberattack.
UnitedHealth Group's Q1 2024 revenues reached $99.8 billion, a year-over-year increase of nearly $8 billion. The company faced a net loss of $1.53 per share due to currency effects from the Brazil sale and the Change Healthcare cyberattack, which had a $0.74 per share impact. Adjusted earnings were $6.91 per share, including $0.25 in business disruption impacts from the cyberattack.
- Revenues grew nearly $8 billion year over year to $99.8 billion.
- Net loss of $1.53 per share was primarily due to currency effects of the Brazil sale and the cyberattack.
- Adjusted earnings were $6.91 per share, including $0.25 in business disruption impacts from the cyberattack.
- The company provided over $6 billion in advance funding and interest-free loans to support care providers affected by the cyberattack.
Headline financials
Revenue & EPS history
UnitedHealth · Revenue · Quarterly
$99.8B
Revenue by segment
UnitedHealth · $92.4B total across 4 segments · Q3 2023
- Premiums$72.3B+12.2%78.3%
- Products$10.4B+12.7%11.2%
- Services$8.67B+29.4%9.4%
- Investment & Other$997M+94.3%1.1%
Forward guidance
The company updated its full year 2024 net earnings outlook to $17.60 to $18.20 per share to reflect the Brazil sale and the estimated direct response costs of the cyberattack. The company maintained its adjusted net earnings outlook of $27.50 to $28.00 per share. This adjusted earnings per share outlook excludes the impacts of the direct response costs and Brazil sale, while including the estimated $0.30 to $0.40 per share of business disruption impacts for the affected Change Healthcare services.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2024
+0.9%
Avg return
Earnings day
+1.3%
Avg return
5 days after
+2.6%
Avg return
30 days after
63%
46 / 73 earnings
Positive
+11.2%
Q2 2024
Best reaction
-22.4%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | +9.7% | +18.1% | |
| Q4 2025 | -11.2% | -18.4% | -18.5% | |
| Q3 2025 | +0.1% | -6.7% | -9.9% | |
| Q2 2025 | +0.6% | +21.2% | +38.2% | |
| Q1 2025 | -22.4% | -27.0% | -50.1% | |
| Q4 2024 | -6.2% | -3.4% | -3.7% | |
| Q3 2024 | -5.6% | -5.9% | -2.0% | |
| Q2 2024 | +11.2% | +9.7% | +12.5% | |
| Q1 2024 | +7.5% | +12.5% | +17.0% | |
| Q4 2023 | -3.8% | -2.7% | -4.0% | |
| Q3 2023 | +2.4% | +2.0% | +3.0% | |
| Q2 2023 | +8.1% | +12.5% | +13.5% | |
| Q1 2023 | -4.0% | -7.6% | -6.7% | |
| Q4 2022 | -2.1% | -3.9% | -0.3% | |
| Q3 2022 | +2.3% | +2.0% | +2.4% | |
| Q2 2022 | +3.4% | +3.4% | +8.2% | |
| Q1 2022 | -0.5% | +0.1% | -9.6% | |
| Q4 2021 | +0.4% | +0.3% | +1.5% | |
| Q3 2021 | +6.1% | +5.2% | +13.7% | |
| Q2 2021 | +1.2% | -0.4% | -1.2% | |
| Q1 2021 | +4.1% | +5.6% | +9.1% | |
| Q4 2020 | +0.8% | -1.2% | -7.8% | |
| Q3 2020 | -2.1% | -2.2% | +7.3% | |
| Q2 2020 | -0.4% | -1.6% | +4.9% | |
| Q1 2020 | +10.3% | +4.3% | +7.6% | |
| Q4 2019 | +4.3% | +3.5% | +3.7% | |
| Q3 2019 | +7.4% | +11.2% | +16.0% | |
| Q2 2019 | -3.8% | -4.4% | -7.9% | |
| Q1 2019 | -5.8% | -3.7% | +2.9% | |
| Q4 2018 | +5.4% | +7.0% | +7.0% | |
| Q3 2018 | +2.7% | +1.9% | +1.8% | |
| Q2 2018 | -0.6% | -1.7% | +2.4% | |
| Q1 2018 | +2.6% | +2.1% | +5.5% | |
| Q4 2017 | +4.3% | +6.4% | -1.1% | |
| Q3 2017 | +6.2% | +7.4% | +9.3% | |
| Q2 2017 | +1.5% | +2.9% | +3.4% | |
| Q1 2017 | +1.2% | +2.4% | +2.6% | |
| Q4 2016 | -2.5% | -1.9% | +1.1% | |
| Q3 2016 | +7.6% | +8.4% | +12.4% | |
| Q2 2016 | +1.6% | +2.1% | +1.0% | |
| Q1 2016 | +4.8% | — | — | |
| Q4 2015 | +5.1% | — | — | |
| Q3 2015 | -1.7% | — | — | |
| Q2 2015 | -1.6% | — | — | |
| Q1 2015 | +1.2% | — | — | |
| Q4 2014 | +7.8% | — | — | |
| Q3 2014 | +7.3% | — | — | |
| Q2 2014 | +2.1% | — | — | |
| Q1 2014 | -4.1% | — | — | |
| Q4 2013 | -3.1% | — | — | |
| Q3 2013 | -8.6% | — | — | |
| Q2 2013 | +7.9% | — | — | |
| Q1 2013 | -3.2% | — | — | |
| Q4 2012 | +1.7% | — | — | |
| Q3 2012 | -2.6% | — | — | |
| Q2 2012 | -1.7% | — | — | |
| Q1 2012 | +3.8% | — | — | |
| Q4 2011 | +2.3% | — | — | |
| Q3 2011 | -2.2% | — | — | |
| Q2 2011 | -1.7% | — | — | |
| Q1 2011 | +0.5% | — | — | |
| Q4 2010 | +0.7% | — | — | |
| Q3 2010 | -0.5% | — | — | |
| Q2 2010 | +1.6% | — | — | |
| Q1 2009 | -0.8% | — | — | |
| Q1 2010 | -0.2% | — | — | |
| Q4 2009 | +0.4% | — | — | |
| Q4 2007 | +0.4% | — | — | |
| Q3 2008 | +5.5% | — | — | |
| Q3 2009 | +5.5% | — | — | |
| Q4 2008 | +1.3% | — | — | |
| Q2 2008 | +1.3% | — | — | |
| Q2 2009 | +1.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro